- Visibility 49 Views
- Downloads 43 Downloads
- Permissions
- DOI 10.18231/j.ijpp.57860.1758806468
-
CrossMark
Unmasking Takayasu Arteritis in a patient with steroid-induced Cushing syndrome
- Author Details:
-
Rengaraj Thirunanamoorthy
-
Thaslim Ridhwana Barakath *
-
Vignesh Vaithiyanathan
-
Vilvarajeshwaran Balamurugan
-
Dhinesh Vaithiyanathan
Rengaraj Thirunanamoorthy
Thaslim Ridhwana Barakath *
Vignesh Vaithiyanathan
Vilvarajeshwaran Balamurugan
Dhinesh Vaithiyanathan
Prolonged corticosteroid use causes Cushing syndrome to emerge with characteristic features like moon face, central obesity, buffalo hump, striae and hypertension. However, the use of corticosteroids also can mask underlying autoimmune conditions, delaying diagnosis. We describe the case of a 25-year-old women who initially presented with complaints of wide-spread body pain and obesity. Further examination ensured cushingoid features due to prolonged self-medication with tablet prednisolone of dose 5mg taken orally. On gradual steroid tapering, she developed limb claudication, unequal blood pressure and pulse discrepancies. Elevated inflammatory markers strengthened the suspicion of Takayasu arteritis, a large vessel arthritis. This case emphasizes the importance of evaluating potential underlying inflammatory diseases in individuals exhibiting exogenous cushingoid features, especially when unexplained vascular signs emerge. Unsupervised corticosteroid use not only increases the risk of adverse effects but may delay the diagnosis of serious conditions, emphasizing the need for cautious prescribing and public awareness.
References
- Nappi E, Keber E, Paoletti G, Casini M, Carosio C, Romano F et al. Oral corticosteroid abuse and self-prescription in Italy: a perspective from community pharmacists and sales reports before and during the COVID-19 era. J Pers Med. 2023;13(5):1–13.
- Shaik S. Case report on steroid induced Cushing syndrome. J Drug Deliv Ther. 2019;9(4):598-600.
- Hemlata, Kishore K. Concomitant Takayasu arteritis and Cushing syndrome in a child undergoing open adrenalectomy: An anaesthetic challenge. Indian J Anaesth. 2014;58(4):467–9.
- Ahamad SK, Sreeteja P, Shravani V, Chandraprakash G, Rao TR. Takayasu arteritis with concurrent Cushing’s syndrome: a case report. Int J Health Sci Res. 2024;14(12):164–8.
- Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002;55(7):481–6.
- Parakh R, Yadav A. Takayasu’s arteritis: an Indian perspective. Eur J Vasc Endovasc Surg. 2007;33(5):578–82.
- Hodgens A, Sharman T. Corticosteroids. Treasure Island (FL). StatPearls Publishing; 2025. Available from: https://www.ncbi. nlm.nih.gov/books/NBK554612/
- Das S, Kaushik J, Dube AS, Biswas P, Jamal F, Kumari S. Prednisolone induced exogenous Cushing syndrome: a case report. J Curr Med Res Opin. 2023;6(10):1762–5.
- Grayson PC, Ponte C, Suppiah R, Robson JC, Gribbons KB, Craven A, et al. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Ann Rheum Dis. 2022;81(12):1654–60.
- Liew SY, Akker SA, Guasti L, Pittaway JFH. Glucocorticoid replacement therapies: past, present and future. Curr Opin Endocr Metab Res. 2019;8:152–9.
- Hahn BH, McMahon M, Wilkinson A, Wallace WD, Daikh DI, FitzGerald J et al. American College of Rheumatology guidelines for screening, treatment and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012;64(6):797–808. Cite this article: Thirunanamoorthy R, Barakath TR, Vaithiyanathan V, Balamurugan V, Vaithiyanathan D. Unmasking Takayasu Arteritis in a patient with steroid-induced Cushing syndrome. Indian J Pharma Pharmacol. 2025;12(3):186-189